portfolio detail ARVINAS

Venture Portfolio

Arvinas

CEO: John Houston

Year Established:
2012

About:
Arvinas is a pharmaceutical company focused on developing novel therapeutics to treat a variety of diseases, including cancer, pro-inflammatory, autoimmune and rare diseases. Central to Arvinas’s proprietary approach is the targeting of disease-causing proteins for degradation, thus eliminating them from the body.

Website:
www.arvinas.com

CI Representative:
Daniel Wagner
Managing Director, Investments

back to portfolio